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Abstract
Background: Radix Wikstroemiae is a common Chinese herbal medicine. The ethyl acetate fraction of the ethanolic 
extract of W. indica possesses potent in vitro antiviral activity against respiratory syncytial virus (RSV). This study aims to 
identify the antiviral components of the active fraction.
Methods: The active fraction of the Radix Wikstroemiae extract was isolated with chromatographic methods such as 
silica gel, Sephadex LH-20 and semi-preparative high performance liquid chromatography (HPLC) columns. The 
structures of the isolated compounds were determined based on spectroscopic analyses. The in vitro antiviral activity of 
the compounds against RSV was tested with the cytopathic effect (CPE) reduction assay and the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method.
Results: Four biflavonoids, namely neochamaejasmin B, genkwanol B, genkwanol C and stelleranol, were isolated and 
characterized. Genkwanol B, genkwanol C and stelleranol, which are stereo isomers of spirobiflavonoids, showed 
potent anti-RSV activity whereas neochamaejasmin B did not.
Conclusion: Neochamaejasmin B, genkwanol B, genkwanol C and stelleranol were isolated from Radix Wikstroemiae 
and the complete absolute configurations of five chiral carbons in stelleranol were substantiated for the first time. 
Furthermore, the anti-RSV activity of genkwanol B, genkwanol C and stelleranol was reported for the first time.
Background
The root of Wikstroemia indica (Linn.) C. A. Mey.
(Thymelaeaceae) (Radix Wikstroemiae,  Liaogewanggen)
is a Chinese herbal medicine used to treat various inflam-
matory conditions [1]. W. indica tablet, an over-the-
counter product made from the aqueous extract of Radix
Wikstroemiae, is commercially available in China for the
treatment of bronchitis, pneumonia, tonsillitis, parotitis
and mastitis according to the Pharmacopoeia of China
[2]. Moreover, W. indica have antifungal, anti-inflamma-
tory, anti-cancer, antiviral and antimalarial effects [3-6].
Bioactive components of W. indica include (+)-nortra-
chelogenin, bis-5,5-nortrachelogenin, tricin, genkwanol
A, kaempferol-3-O-beta-D-glucopyranoside, wikstrol A,
wikstrol B, daphnodorin B, sikokianin B, sikokianin C,
indicanone, lirioresinol B and daphnoretin [3-8]. In our
previous study, the ethyl acetate fraction of the ethanolic
extract of Radix Wikstroemiae possessed in vitro antiviral
activity against RSV with IC50 value of < 3.9 μg/ml and
selective index (SI) of > 64.1. Besides, daphnoretin (a
dicoumarin compound) is one of the active components
in the fraction, which mainly exerts its antiviral effects on
the later phase of the viral replication cycle [9]. This arti-
cle reports the isolation, structural characterization and
in vitro antiviral tests of four biflavonoids, namely, (I)
neochamaejasmin B, (II) genkwanol B, (III) genkwanol C
and (IV) stelleranol from the ethyl acetate fraction of the
ethanolic extract of Radix Wikstroemiae.
Methods
Plant material
Radix Wikstroemiae was purchased from a Chinese med-
icine pharmacy in Guangzhou, China. The authentication
process was carried out by Zhengqiu Mai (Chinese
Medicinal Material Company, Guangzhou, China)
according to standard protocols [2]. A voucher specimen
was deposited in the Institute of Traditional Chinese
Medicine and Natural Products, College of Pharmacy,
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Jinan University (Guangzhou, China) with an accession
number of 06111205.
General experimental procedures
Optical rotations were determined on a Jasco P-1020 dig-
ital polarimeter (JASCO Corporation, Japan). The spec-
tra of electrospray ionization-mass spectrometry (ESI-
MS) were recorded on a Finnigan LCQ Advantage Max
ion trap mass spectrometer (Thermo Finnigan, USA).
The spectra of high resolution-electrospray ionization-
mass spectrometry (HR-ESI-MS) were acquired with a
Micromass Q-TOF mass spectrometer (Waters Corpora-
tion, USA). The spectra of nuclear magnetic resonance
spectrometry (NMR) including proton magnetic reso-
nance spectrometry (1H-NMR) and carbon magnetic res-
onance spectrometry (13C - N M R )  w e r e  o b t a i n e d  o n  a
Bruker spectrometer (Bruker Corporation, Switzerland)
operating at 500 MHz for 1H-MNR and 125 MHz for 13C-
NMR respectively. The isolation process was conducted
on silica gel (200-300 meshes, Qingdao Marine Chemical,
China), Sephadex LH-20 (25-100 μm, Fluka, Switzerland)
and semi-preparative HPLC. Semi-preparative HPLC was
performed on an Eclipse XDB-C18 column (9.4 mm ID ×
25 cm) (Agilent Technologies, USA). Thin layer chroma-
tography (TLC) was carried out on silica gel GF254 plates
(0.2 mm thickness, 10 × 20 cm, Qingdao Marine Chemi-
cal, China) with FeCl3-EtOH reagent and ultraviolet (UV)
illumination as chromogenic methods.
Extraction and isolation
The dried and cut Radix Wikstroemiae (10.0 kg) was
soaked in 95% ethanol at room temperature for three
times (15 days each time). The ethanol solutions were
then combined and concentrated in vacuo to yield a dark
brown crude extract (1.0 kg). The ethanol extract was
suspended in distilled water and partitioned with petro-
leum ether, ethyl acetate and n-butanol successively. After
evaporation under reduced pressure, the petroleum ether
fraction (5.0 g), ethyl acetate fraction (580.0 g) and
butanol fraction (400.0 g) were obtained respectively.
The ethyl acetate fraction (550.0 g) was chromato-
graphed on a silica gel column eluted with a solvent sys-
tem of petroleum ether/ethyl acetate in gradient to obtain
28 subfractions based on the TLC analysis. The subfrac-
tions Fr-12 and Fr-23, which yielded positive reaction
with FeCl3-EtOH reagent, were further isolated.
Fr-12 (12.6 g) was isolated with repeated silica gel col-
umns eluted with gradient solvent systems of chloro-
form/acetone and chloroform/methanol, respectively,
followed by Sephadex LH-20 column eluted with chloro-
form/methanol (3/7) to yield compound I (20.0 mg).
Fr-23 (12.6 g) was subjected to repeated silica gel col-
umns eluted with gradient solvent system of chloroform/
methanol, followed by semi-preparative HPLC on an
Eclipse XDB-C18  column (Agilent Technologies, USA)
with a gradient solvent system of 0.1% TFA (A) and meth-
anol (B) to yield compounds II (40.7 mg), III (60.3 mg)
and IV (20.7 mg).
Identification
Compound I (neochamaejasmin B), an amorphous brown
powder, was positive to FeCl3-EtOH reagent. [α]D = 200°
(c 0.1, MeOH). ESI-MS: m/z 541 [M-H] - .1 H-NMR (500
MHz, CD3OD) δ: 7.17 (2H, d, J = 8.4 Hz, H-2''', H-6'''),
6.94 (2H, d, J = 8.4 Hz, H-2', H-6'), 6.81 (2H, d, J = 8.4 Hz,
H-3''', H-5'''), 6.67 (2H, d, J = 8.4 Hz, H-3', H-5'), 6.00 (1H,
d, J = 1.8 Hz, H-8''), 5.89 (1H, d, J = 1.8 Hz, H-8), 5.80 (1H,
d, J = 1.8 Hz, H-6''), 5.78 (1H, d, J = 1.8 Hz, H-6), 5.57 (1H,
d, J = 4.6 Hz, H-2), 5.16 (1H, d, J = 8.8 Hz, H-2''), 3.29 (1H,
dd, J = 3.2, 8.8 Hz, H-3''), 3.16 (1H, brs, H-3). 13C-NMR
(125 MHz, CD3OD) δ: 198.6 (C-4''), 196.3 (C-4), 168.3 (C-
7''), 168.1 (C-7), 165.1 (C-8''a), 165.4 (C-5''), 165.2 (C-5),
163.4 (C-8a), 159.0 (C-4'''), 158.6 (C-4'), 130.3 (C-2''', 6'''),
129.1 (C-1'''), 128.8 (C-1'), 128.5 (C-2', 6'), 116.4 (C-3''',
5'''), 116.2 (C- 3', 5'), 105.1 (C-4''a) ,103.9 (C-4a), 97.3 (C-
6''), 97.1 (C-6), 96.4 (C-8''), 96.0 (C-8), 83.3 (C-2''), 81.5
(C-2), 50.8 (C-3''), 49.7 (C-3).
Compound II (genkwanol B), a light yellow powder, was
positive to FeCl3-EtOH reagent. [α]D  = -160° (c  0.1,
MeOH). HR-ESI-MS m/z: 557.10805 [M-H] - .1 H-NMR
(500 MHz, DMSO-d6) δ: 7.09 (2H, d, J = 8.5 Hz, H-2''', H-
6'''), 6.73 (2H, d, J = 8.5 Hz, H-3''', H-5'''), 6.58 (2H, d, J =
8.5 Hz, H-2', H-6'), 6.51 (2H, d, J = 8.5 Hz, H-3', H-5'),
6.11 (1H, d, J = 2.0 Hz, H-8''), 6.04 (1H, d, J = 2.0 Hz, H-
6''), 5.71 (1H, s, H-6), 4.56 (1H, d, J = 8.2 Hz, H-2), 3.55
(1H, m, H-3), 2.59 (1H, dd, J = 8.9, 16.7 Hz, H-4), 2.05
(1H, dd, J  = 5.0, 16.7 Hz, H-4). 13C-NMR (125 MHz,
DMSO-d6) δ: 190.4 (C-4''), 186.3 (C-5), 168.6 (C-7), 167.7
(C-7''), 163.3 (C-5''), 160.1 (C-8''a), 158.1 (C-4'''), 157.9(C-
8a), 156.7 (C-4'), 129.8 (C-2''', 6'''), 127.9 (C-1'), 127.3 (C-
2', 6'), 122.0 (C-1'''), 114.6 (C-3''', 5'''), 114.4 (C-3', 5'),
109.2 (C-4a) ,100.4 (C-6), 99.8 (C-4''a), 97.0 (C-6''), 96.1
(C-8''), 89.9 (C-2''), 85.0 (C-8), 82.0 (C-2), 79.8 (C-3''), 66.4
(C-3), 27.0 (C-4).
Compound III (genkwanol C), a light yellow powder,
was positive to FeCl3-EtOH reagent. [α]D = +15° (c 0.1,
MeOH). HR-ESI-MS m/z: 557.10863 [M-H] -.  1H-NMR
(500 MHz, DMSO-d 6) δ: 7.07 (2H, d, J = 8.5 Hz, H-2''', H-
6'''), 6.96 (2H, d, J = 8.5 Hz, H-2', H-6'), 6.74 (2H, d, J = 8.5
Hz, H-3''', H-5'''), 6.51 (2H, d, J = 8.5 Hz, H-3', H-5'), 6.00
(1H, d, J = 2.0 Hz, H-8''), 5.93 (1H, d, J = 2.0 Hz, H-6''),
5.72 (1H, s, H-6), 4.61 (1H, d, J = 6.5 Hz, H-2), 3.77 (1H,
m, H-3), 3.16 (1H, d, J = 6.5 Hz, H-4), 2.21 (1H, d, J = 4.0
Hz, H-4). 13C-NMR (125 MHz, DMSO-d 6) δ: 190.3 (C-
4''), 186.3 (C-5), 168.5 (C-7), 167.3 (C-7''), 162.6 (C-5''),
160.2 (C-8''a), 158.1 (C-8a), 157.3 (C-4'''), 156.7 (C-4'),
129.6 (C-2''', 6'''), 127.8 (C-1'), 127.4 (C-2', 6'), 121.9 (C-Huang et al. Chinese Medicine 2010, 5:23
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1'''), 114.6 (C-3''', 5'''), 114.5 (C-3', 5'), 109.5 (C-4a) ,100.48
(C-6), 99.2 (C-4''a), 97.8 (C-6''), 95.7 (C-8''), 90.4 (C-2''),
84.6 (C-8), 81.8 (C-2), 79.9(C-3''), 65.0(C-3), 25.5 (C-4).
Compound IV (stelleranol), a light yellow powder, was
positive to FeCl3-EtOH reagent. [α]D  = -102° (c  0.1,
MeOH). HR-ESI-MS m/z: 557.10913 [M-H] -. CD (c
6.25×10-5, MeOH) Δε (nm): 0 (394), -6.8 (342), 0 (327),
+31.8 (305), 0 (279), -18.6 (259), -7.5 (242), - 21.2 (219), 0
(206). 1H-NMR (500 MHz, acetone-d6) δ: 7.22 (2H, d, J =
8.5 Hz, H-2''', H-6'''), 6.83 (2H, d, J = 8.5 Hz, H-3''', H-5'''),
6.71 (2H, d, J = 8.5 Hz, H-2', H-6'), 6.62 (2H, d, J = 8.5 Hz,
H-3', H-5'), 6.16 (1H, d, J = 2.0 Hz, H-8''), 6.14 (1H, d, J =
2.0 Hz, H-6''), 6.09 (1H, s, H-2''), 5.68 (1H, s, H-6), 4.96
(1H, s, H-2), 4.18 (1H, brs, H-3), 2.65 (1H, d, J = 17.5 Hz,
H-4), 2.49 (1H, dd, J = 3.8, 17.3 Hz, H-4). 13C-NMR (125
MHz, acetone-d6) δ: 193.1 (C-4''), 188.7 (C-5), 170.4 (C-
7), 169.6 (C-7''), 166.1 (C-8''a), 163.1 (C-5''), 160.3 (C-8a),
159.9 (C-4'''), 158.6 (C-4'), 131.7 (C-2''', 6'''), 130.4 (C-1'),
129.2 (C-2', 6'), 124.7 (C-1'''), 116.7 (C-3''', 5'''), 116.5 (C-3',
5'), 111.1 (C-4a) ,102.9 (C-6), 102.0 (C-4''a), 99.0 (C-6''),
98.4 (C-8''), 92.2 (C-2''), 87.5 (C-8), 82.3 (C-2), 82.1 (C-3''),
66.5 (C-3), 28.6 (C-4).
Cell and virus
Human larynx epidermoid carcinoma cell line (HEp-2,
CCL-23) and RSV (long strain, VR-26) were purchased
from the American Type Culture Collection (ATCC,
USA). The cells were grown in Eagle's minimum essential
Figure 1 The chemical structures of biflavonoids I-IV.
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medium (EMEM) (Gibco, USA) supplemented with 10%
fetal bovine serum (FBS) (Gibco, USA), 25 μg/ml gentam-
icin (Sigma, USA) and 200 mM L-glutamine (Sigma,
USA) (growth medium). Virus-infected cells were main-
tained in EMEM with 1% FBS, 25 μg/ml gentamicin and
200 mM L-glutamine (maintenance medium). All the
cells were cultured at 37°C in a humidified atmosphere
supplied with 5% CO2. Virus titers were determined by
the 50% tissue culture infective dose (TCID50) method.
Cytotoxicity assay
Cell viability was tested by the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) method as
described in previous study [10]. Briefly, 100 μl of two-
fold diluted samples were added to a 96-well plate con-
taining confluent cell monolayer in triplicates while the
dilution medium without the sample was the control.
After 72 hours of incubation, 12 μl of the MTT solution
(5 mg/ml in phosphate buffered saline) was added to each
well. The trays were further incubated for four hours for
the formation of blue formazan. After the supernatant
was removed, the blue formazan was solubilized in 100 μl
DMSO and the optical density (OD) was measured at 570
nm with a microplate reader.
Antiviral assay
CPE reduction assay was adopted for screening the in
vitro antiviral activity as described in the previous study
[10]. Briefly, 0.1 ml of 100 TCID50 virus suspension and
serial two-fold dilutions of the tested samples were added
simultaneously to confluent cell monolayers in a 96-well
plate. Virus suspension and maintenance medium with-
out samples were added as the virus control and cell con-
trol, respectively. The plates were incubated at 37°C in a
humidified CO2  atmosphere for 3-5 days. The virus-
induced CPE was scored against the virus control under a
light microscope. Ribavirin (Sigma, USA) was used as
positive control in this experiment.
Results
Chemical structures of the isolated compounds
Compound IV was isolated as a light yellow powder. Posi-
tive FeCl3  reaction showed the presence of phenolic
hydroxyl groups. The molecular formula of compound IV
was determined to be C30H22O11 by HR-ESI-MS (m/z
557.10931 [M-H] -, calcd. for C30H21O11 m/z 557.10893).
Proton and carbon signals were assigned by a combina-
tion of 1D- and 2D-NMR spectra. The 1H-NMR spec-
trum of compound IV showed signals assignable to a pair
of 1,4-disubstituted aromatic rings [δ 7.22 (2H, d, J = 8.5
Hz), 6.71 (2H, d, J = 8.5 Hz), 6.83 (2H, d, J = 8.5 Hz), and
6.62 (2H, d, J = 8.5 Hz)], one 1,2,4,6-tetra substituted aro-
matic ring [δ 6.16 (1H, d, J = 2.0 Hz), and 6.14 (1H, d, J =
2.0 Hz)] and one 3-hydroxy-2,5,6-trisubstituented dihy-
dropyran [δ 4.96 (1H, s), 4.18 (1H, brs), 2.65 (1H, d, J =
17.5 Hz), 2.49 (1H, dd, J = 3.8, 17.3 Hz)]. Moreover, two
Table 1: In vitro anti-RSV activity of compounds I-IV (n = 3)
Compound CC50(μM) a IC50 (μM) b SI
I 29.9 (3.2) - -
II 106.1 (5.9) 9.6 (0.7) 11.0
III 145.3 (3.1) 6.6 (1.1) 21.9
IV 161.5 (5.7) 10.2 (0.8) 15.8
Ribavirin 256.1 (3.2) 11.9 (0.2) 21.6
a CC50 is the concentration of sample with half maximal inhibition on the growth and survival of HEp-2 cells; data are expressed as mean (SD).
b IC50 is the concentration that reduced 50% of CPE in respect to virus control; data are expressed as mean (SD).
-: The sample did not show anti-RSV effect at its NMCC.
Figure 2 The CD spectra of biflavonoid IV in MeOH.Huang et al. Chinese Medicine 2010, 5:23
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singlet signals were observed at δ 6.09 (1H, s) and 5.68
(1H, s). In the 13C-NMR spectrum of compound IV, two
carbonyl carbons (δ 193.1 and 188.7) and two quaternary
c a r bo n s  w i t h  a t t a c h m e n t  o f  o x y g e n  a t o m s  ( δ  87.5 and
82.1) were observed in addition to the signals described
above. The 1H-NMR and 13C-NMR data of compound IV
were consistent with those of stelleranol [11,12]. There
were five chiral carbons including C-2, C-3, C-8, C-2'',
and C-3'' in the structure of stelleranol (Figure 1). Among
them, the absolute configurations at both C-2 and C-3
were determined to be R according to comparison of the
NMR data of stelleranol with the published data of (-)-
epicatechin [11,12]. The absolute configurations of
another three carbons, namely C-8, C-2'' and C-3'', were
determined by comparison of the CD spectrum of com-
pound IV with those of genkwanol B (2) and genkwanol C
(3) [13]. The CD spectrum of compound IV (Figure 2)
was similar to that of genkwanol C, and opposite to that
of genkwanol B. Therefore, the absolute configurations at
C-2, C-3, C-8, C-2'' and C-3'' positions of stelleranol were
fully substantiated to be R, R, R, R and S.
We also identified compounds I-III to be neochamae-
jasmin B (I), genkwanol B (II), genkwanol C (III) by com-
paring their spectra with the published data [13-15].
Compound I was a biflavonone whereas compounds II-
IV were stereo isomers of spirobiflavonoids (Figure 1).
Antiviral activity of the isolated compounds
The in vitro antiviral activity of compounds I-IV against
RSV was tested with CPE reduction assay and the MTT
method. The SI value calculated from the ratio of CC50 to
IC50 was used as an important parameter to evaluate the
in vitro antiviral activity of the compounds. Compounds
II, III and IV showed similar in vitro antiviral activity
against RSV with IC50 values of 9.6, 6.6, 10.2 μM and SI
values of 11.0, 21.9, 15.8 respectively whereas compound
I did not show anti-RSV effect in its maximal non-cyto-
toxic concentration (MNCC), the highest concentration
tested in the CPE reduction assay (Table 1).
Discussion
Quite a few biflavonoids possess antiviral activities
against a number of viruses such as RSV [4,16-20]. Bifla-
vonoids isolated from Radix Wikstroemiae, e.g. (+)-nor-
trachelogenin, genkwanol A, wikstrol B and daphnodorin
B, are moderately active against HIV-1 in vitro [4]. How-
ever, the anti-RSV activity of biflavonoids from W. indica
has not been discussed before. Three spirobiflavonoids II,
III and IV possess similar potent anti-RSV activity to the
positive controlled drug ribavirin. In addition, stelleranol
is a spirobiflavonoid consisted of five chiral carbons. The
absolute configurations of the five chiral carbons in stelle-
ranol are completely substantiated in this study, and the
CD spectrum of stelleranol has been given for the first
time.
Conclusion
Neochamaejasmin B, genkwanol B, genkwanol C and
stelleranol were isolated from Radix Wikstroemiae and
the complete absolute configurations of five chiral car-
bons in stelleranol were substantiated for the first time.
Furthermore, the anti-RSV activity of genkwanol B, genk-
wanol C and stelleranol was reported for the first time.
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